A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial David A. MorrowChaim M. BrickmanAndrew L. Salzman OriginalPaper 06 June 2008 Pages: 359 - 364
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials Giuseppe De LucaEttore CassettiPaolo Marino OriginalPaper 23 May 2008 Pages: 365 - 378
Adherence to guidelines for the management of excessive warfarin anticoagulation Emily B. DevineAlan W. HopeflAnn K. Wittkowsky OriginalPaper 09 May 2008 Pages: 379 - 384
The smoker’s paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome Peter C. KievitMarc A. BrouwerFreek W. A. Verheugt OriginalPaper Open access 26 June 2008 Pages: 385 - 393
Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery Frantisek BednarPavel OsmancikTomas Vanek OriginalPaper 01 May 2008 Pages: 394 - 399
Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effect on the development of the post-thrombotic syndrome E. M. Roumen-KlappeM. den HeijerM. C. H. Janssen OriginalPaper Open access 15 May 2008 Pages: 400 - 405
The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy Chris E. HolmesJoe C. HuangMary Cushman OriginalPaper 17 May 2008 Pages: 406 - 412
Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis Giuseppe PattiCarolina FossatiGermano Di Sciascio OriginalPaper 25 June 2008 Pages: 413 - 420
Indications of combined vitamin K antagonists and aspirin therapy A. LoualidiS. H. J. BredieM. C. H. Janssen OriginalPaper Open access 31 May 2008 Pages: 421 - 429
Predictors of unstable anticoagulation in African Americans Larisa H. CavallariJonathan L. AstonEdith A. Nutescu OriginalPaper 19 June 2008 Pages: 430 - 437
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy Victor SerebruanyAlex Malininfor the ALPS Study Group OriginalPaper 03 June 2008 Pages: 438 - 446
Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting Marzenna ZielinskaKrzysztof Kaczmarek OriginalPaper 04 May 2008 Pages: 447 - 452
Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura Shailendra Kapoor OriginalPaper 26 April 2008 Pages: 453 - 453
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified Antonio GirolamiPamela ScarparoSilvia Vettore OriginalPaper 13 March 2009 Pages: 454 - 455
Relationship between Factor XII deficiency and thrombosis: the debate is still open? Gianfranco LessianiAngela FalcoGiovanni Davì OriginalPaper 08 April 2009 Pages: 456 - 457
Ischemic neuropathy and rhabdomyolysis as presenting symptoms of postpartum cardiomyopathy Rick C. G. HelmichHanneke W. M. van LaarhovenMirian C. H. Janssen OriginalPaper Open access 26 June 2008 Pages: 458 - 460
Warfarin in vulnerable older adults with atrial fibrillation S. Michael GharacholouRichard C. Becker News 07 May 2009 Pages: 461 - 464